Your session is about to expire
← Back to Search
NA
Pears + Sweet Potatoes for Infant Development (IMiND Trial)
N/A
Waitlist Available
Led By Jennifer Smilowitz, PhD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Term infants born >37 weeks gestation
Be between 18 and 65 years old
Must not have
Family history of immunodeficiency syndrome(s)
Infants with any GI tract abnormalities
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline, days 14, 19, 25, 29, 60, 90, 120, 150, 180
Awards & highlights
No Placebo-Only Group
Summary
This trial is looking at how a baby's eating habits and gut health affect their development.
Who is the study for?
This trial is for mother-infant pairs near UC Davis, California. Infants must be born full-term and exclusively breastfed for at least 5 months, ready to start solids between 4-7.5 months old without any GI abnormalities or recent antibiotic use. Mothers should be healthy, aged 21-45, non-smokers, and willing to avoid giving infants formula or supplements during the study.
What is being tested?
The study investigates how introducing solid foods like pears and sweet potatoes to exclusively breastfed infants affects their gut microbiome and development. It tracks changes in fecal microbiota as these new foods are introduced and relates them to developmental milestones.
What are the potential side effects?
Since this trial involves common food items (pears and sweet potatoes) given to infants starting on solids, there aren't typical side effects like with medications; however, potential reactions could include normal digestive adjustments or food sensitivities.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My baby was born after 37 weeks of pregnancy.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
My family has a history of immune system disorders.
Select...
My infant has a gastrointestinal (GI) tract abnormality.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline, days 14, 19, 25, 29, 60, 90, 120, 150, 180
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline, days 14, 19, 25, 29, 60, 90, 120, 150, 180
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Incidence of Adverse Events and Treatments
Infant fecal microbial diversity
Infant fecal microbiota composition
Secondary study objectives
Dietary composition
Fecal metabolomics
Glycosidic linkages
+9 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Sweet PotatosExperimental Treatment1 Intervention
Infants will consume commercially available baby food sweet potato (SP) (Plum Organics, Just Sweet Potato) for 7 days followed by a 4 day washout period of exclusive breast milk. Participants will be instructed to offer 1-2 tablespoons of sweet potato to their infant at least three times per day for seven days in a row.
Group II: PearsExperimental Treatment1 Intervention
Infants will consume commercially available baby food pear (P) (Earth's Best, First Pears) for 7 days followed by a 4 day washout period of exclusive breast milk. Participants will be instructed to offer 1-2 tablespoons of pears to their infant at least three times per day for seven days in a row.
Find a Location
Who is running the clinical trial?
UC Davis Foods for Health InstituteUNKNOWN
Mengniu DairyUNKNOWN
University of California, DavisLead Sponsor
945 Previous Clinical Trials
4,756,038 Total Patients Enrolled
1 Trials studying Infant Development
8 Patients Enrolled for Infant Development
Jennifer Smilowitz, PhDPrincipal InvestigatorUniversity of California, Davis
5 Previous Clinical Trials
220 Total Patients Enrolled
Lisa Oakes, PhDPrincipal InvestigatorUniversity of California, Davis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My infant has a gastrointestinal (GI) tract abnormality.My infant has a specific medical condition.I am willing to avoid giving my infant certain foods during the study.My baby was born after 37 weeks of pregnancy.My family has a history of immune system disorders.I am a woman aged 21-45 who has recently given birth to a healthy baby.I am a mother diagnosed with a specific medical condition.My infant has a specific number of bowel movements.My infant is ready to start eating solid foods.I am a healthy woman or have a healthy infant.I am willing to collect milk samples as instructed.My infant has not taken any restricted medications or consumed restricted items recently.
Research Study Groups:
This trial has the following groups:- Group 1: Sweet Potatos
- Group 2: Pears
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.